TransMedics Group (TMDX) PT Raised to $80 at Stifel on Q2 Top-line Beat
Tweet Send to a Friend
Stifel analyst Thomas Stephan raised the price target on TransMedics Group (NASDAQ: TMDX) to $80.00 (from $75.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
